TY - JOUR
T1 - Living Donor Kidney Transplantation in Older Individuals
T2 - An Ethical Legal and Psychological Aspects of Transplantation (ELPAT) View
AU - Courtney, Aisling E.
AU - Moorlock, Greg
AU - Van Assche, Kristof
AU - Burnapp, Lisa
AU - Mamode, Nizam
AU - Lennerling, Annette
AU - Dor, Frank J.M.F.
N1 - Publisher Copyright:
Copyright © 2023 Courtney, Moorlock, Van Assche, Burnapp, Mamode, Lennerling and Dor.
PY - 2023/4/21
Y1 - 2023/4/21
N2 - Living donor transplantation is the optimal treatment for suitable patients with end-stage kidney disease. There are particular advantages for older individuals in terms of elective surgery, timely transplantation, and early graft function. Yet, despite the superiority of living donor transplantation especially for this cohort, older patients are significantly less likely to access this treatment modality than younger age groups. However, given the changing population demographic in recent decades, there are increasing numbers of older but otherwise healthy individuals with kidney disease who could benefit from living donor transplantation. The complex reasons for this inequity of access are explored, including conscious and unconscious age-related bias by healthcare professionals, concerns relating to older living donors, ethical anxieties related to younger adults donating to aging patients, unwillingness of potential older recipients to consider living donation, and the relevant legislation. There is a legal and moral duty to consider the inequity of access to living donor transplantation, recognising both the potential disparity between chronological and physiological age in older patients, and benefits of this treatment for individuals as well as society.
AB - Living donor transplantation is the optimal treatment for suitable patients with end-stage kidney disease. There are particular advantages for older individuals in terms of elective surgery, timely transplantation, and early graft function. Yet, despite the superiority of living donor transplantation especially for this cohort, older patients are significantly less likely to access this treatment modality than younger age groups. However, given the changing population demographic in recent decades, there are increasing numbers of older but otherwise healthy individuals with kidney disease who could benefit from living donor transplantation. The complex reasons for this inequity of access are explored, including conscious and unconscious age-related bias by healthcare professionals, concerns relating to older living donors, ethical anxieties related to younger adults donating to aging patients, unwillingness of potential older recipients to consider living donation, and the relevant legislation. There is a legal and moral duty to consider the inequity of access to living donor transplantation, recognising both the potential disparity between chronological and physiological age in older patients, and benefits of this treatment for individuals as well as society.
UR - https://www.scopus.com/pages/publications/85157986539
U2 - 10.3389/ti.2023.11139
DO - 10.3389/ti.2023.11139
M3 - Article
C2 - 37152615
AN - SCOPUS:85157986539
SN - 0934-0874
VL - 36
JO - Transplant International
JF - Transplant International
M1 - 11139
ER -